Earlier in 2025, the U.S. Food and Drug Administration (FDA) approved Ozempic® (semaglutide ... to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD).

Ozempic (semaglutide) is a brand-name prescription drug used to manage type 2 diabetes and lower the risk of kidney and heart complications in people with both diabetes and chronic kidney disease.

Objective: Patients with chronic kidney disease (CKD) are at higher risk for cardiovascular disease (CVD) than patients in the general population. One potentially modifiable risk factor for CVD in ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

NORTH CAROLINA -- A warning to consumers about fake Ozempic (semaglutide). The FDA issued this alert saying counterfeits have ...

Obesity ‘Strongly’ Linked to 16 Cardiometabolic Diseases The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep apnea ...

revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ... Long-Term Effects of Obesity on Brain and Cognitive Health Apr. 9 ...

She is affiliated with the National Kidney Foundation and the Department of Veterans Affairs. For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar.

University of Pittsburgh Medical School researchers walk us through multiple approaches they’ve tried in the past, are currently using or plan to use in the future, as well as the significant ...

Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are ...

In the US, only half the people who have chronic kidney disease are formally diagnosed — here's what you need to know to prevent the condition from worsening For a disease afflicting 35.5 ...